Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Terephthalamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 known ✓ | P09874 | 2/20 | 0.67 |
| ▸ | CA2 known ✓ | P00918 | 3/20 | 0.59 |
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | RECQL | P46063 | 1/20 | 0.67 |
| ▸ | BLM | P54132 | 1/20 | 0.67 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | PARP10 | Q53GL7 | 10/20 | 0.65 |
| ▸ | PARP4 | Q9UKK3 | 2/20 | 0.65 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Terephthalamide SCHEMBL11512422 | 1.00 | PARP1 (0.67) | PARP1TSHRPOLBCYP3A4MAPT | |
| Terephthalamide SCHEMBL23774 | 0.96 | PARP1 (0.71) | PARP1TSHRPOLBCYP3A4MAPT | |
| Terephthalamide SCHEMBL27703657 | 0.93 | PARP1 (0.67) | PARP1TSHRPOLBCYP3A4MAPT | |
| Terephthalamide SCHEMBL28360111 | 0.93 | PARP1 (0.67) | PARP1TSHRPOLBCYP3A4MAPT | |
| Terephthalamide SCHEMBL27281597 | 0.93 | PARP1 (0.67) | PARP1TSHRPOLBCYP3A4MAPT | |
| Terephthalamide SCHEMBL7508927 | 0.93 | PARP1 (0.67) | PARP1TSHRPOLBCYP3A4MAPT | |
| Terephthalamide SCHEMBL15328883 | 0.93 | PARP1 (0.67) | PARP1TSHRPOLBCYP3A4MAPT | |
| Terephthalamide SCHEMBL29102653 | 0.93 | PARP1 (0.67) | PARP1TSHRPOLBCYP3A4MAPT | |
| Terephthalamide SCHEMBL689841 | 0.93 | PARP1 (0.67) | PARP1TSHRPOLBCYP3A4MAPT | |
| Terephthalamide SCHEMBL1906838 | 0.93 | PARP1 (0.67) | PARP1TSHRPOLBCYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120005209-A | Photochromic hydrogen bond organic framework material and preparation method and application thereof | 陕西科技大学 | 2025-05-16 | — | — | CN | claimed |
| CN-119456029-A | Preparation method and application of nano-enzyme with efficient bacterial capturing capability and double catalytic activities | 郑州大学 | 2025-02-18 | — | — | CN | claimed |
| CN-118325008-A | Preparation method of crystalline polar covalent triazine framework material and photo-thermal coupling catalytic application | 中国石油大学(华东) | 2024-07-12 | — | — | CN | claimed |
| CN-118198743-A | Nitrogen-containing covalent triazine frame type microwave absorbing carbon material and preparation method and application thereof | 西安交通大学 | 2024-06-14 | — | — | CN | claimed |
| CN-115386083-B | 3, 4-ethylenedioxythiophene covalent triazine framework and synthetic method and application thereof | 河南农业大学 | 2024-02-27 | — | — | CN | claimed |
| CN-116695171-A | Fe 3 C@C composite nano catalyst and preparation method and application thereof | 西华师范大学 | 2023-09-05 | — | — | CN | claimed |
| CN-116622067-A | Hydrophilic covalent triazine frame and preparation method and application thereof | 齐鲁工业大学(山东省科学院) | 2023-08-22 | — | — | CN | claimed |
| CN-116041356-A | Monophenol functionalized cucurbituril derivative and preparation method thereof | 华东理工大学 | 2023-05-02 | — | — | CN | claimed |
| CN-113958013-B | Novel energy-saving environment-friendly multifunctional integrated wallboard | 定州市筑业装配式建筑科技有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-115414966-B | Carbon quantum dot doped covalent triazine framework composite material, and preparation method and application thereof | 山东环投环境工程有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-113845665-A | Full-conjugated organic triazine framework material and preparation method and application thereof | 天津大学 | 2021-12-28 | — | — | CN | claimed |
| CN-111362834-B | Antibacterial amidine oligomer with drug resistance and preparation method and application thereof | 湖南大学 | 2021-04-02 | — | — | CN | claimed |
| CN-111362834-A | Antibacterial amidine oligomer with drug resistance and preparation method and application thereof | 湖南大学 | 2020-07-03 | — | — | CN | claimed |
| CN-110869466-A | Low-dimensional inorganic/organic hybrid metal halide perovskites | 南洋理工大学 | 2020-03-06 | — | — | CN | claimed |
| WO-2008116165-A9 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | NEXT SAFETY INC (US) | 2009-06-11 | — | — | WO | claimed |
| EP-2032124-A1 | MULTIPARTICULATE OSMOTIC DELIVERY SYSTEM | BIOVAIL LABORATORIES INTERNATIONAL SRL (BB) | 2009-03-11 | — | — | EP | claimed |
| US-20090004281-A1 | MULTIPARTICULATE OSMOTIC DELIVERY SYSTEM | BIOVAIL LABORATORIES INTERNATIONAL S.R.L. (BB) | 2009-01-01 | — | — | US | claimed |
| WO-2008116165-A2 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | NEXT SAFETY, INC. (US) | 2008-09-25 | — | — | WO | claimed |
| US-20080066741-A1 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | HUNTER, CHARLES ERIC | 2008-03-20 | — | — | US | claimed |
| WO-2008001341-A1 | MULTIPARTICULATE OSMOTIC DELIVERY SYSTEM | BIOVAIL LABORATORIES INTERNATIONAL SRL (BB) | 2008-01-03 | — | — | WO | claimed |